Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 344

1.

Comparisons of the clinical outcomes between early- and adult-onset bipolar disorders: A prospective cohort analysis.

Liu SK, Chang JC, Tsai HJ, Wu CS.

J Affect Disord. 2019 Aug 28;260:1-10. doi: 10.1016/j.jad.2019.08.084. [Epub ahead of print]

PMID:
31493631
2.

Correlation between serum indicators of child obesity metabolic syndrome and the incidence of cardiovascular diseases.

Chen ZZ, Liu SK.

J Biol Regul Homeost Agents. 2019 Sep 5;33(5). [Epub ahead of print] No abstract available.

PMID:
31487980
3.

MicroRNA‑198 suppresses prostate tumorigenesis by targeting MIB1.

Ray J, Hoey C, Huang X, Jeon J, Taeb S, Downes MR, Boutros PC, Liu SK.

Oncol Rep. 2019 Sep;42(3):1047-1056. doi: 10.3892/or.2019.7234. Epub 2019 Jul 15.

4.

Complete atrioventricular block during thoracic endovascular aortic repair.

Shyu HN, Li PH, Liu SK, Chiang YY.

Ann Card Anaesth. 2019 Jul-Sep;22(3):325-327. doi: 10.4103/aca.ACA_68_18.

5.

Effects of UGT1A1 Polymorphism, Gender and Triglyceride on the Pharmacokinetics of Telmisartan in Chinese Patients with Hypertension: A Population Pharmacokinetic Analysis.

Huang L, Yang L, Huang J, Tan HY, Liu SK, Guo CX, Zuo XC, Yang GP, Pei Q.

Eur J Drug Metab Pharmacokinet. 2019 Jun 28. doi: 10.1007/s13318-019-00567-7. [Epub ahead of print]

PMID:
31254178
6.

Inhibitory effects of oxymatrine on hepatic stellate cells activation through TGF-β/miR-195/Smad signaling pathway.

Song LY, Ma YT, Fang WJ, He Y, Wu JL, Zuo SR, Deng ZZ, Wang SF, Liu SK.

BMC Complement Altern Med. 2019 Jun 20;19(1):138. doi: 10.1186/s12906-019-2560-2.

7.

Circulating miRNAs as non-invasive biomarkers to predict aggressive prostate cancer after radical prostatectomy.

Hoey C, Ahmed M, Fotouhi Ghiam A, Vesprini D, Huang X, Commisso K, Commisso A, Ray J, Fokas E, Loblaw DA, He HH, Liu SK.

J Transl Med. 2019 May 23;17(1):173. doi: 10.1186/s12967-019-1920-5.

8.

Adverse Respiratory Events Increase Post-anesthesia Care Unit Stay in China: A 2-year Retrospective Matched Cohort Study.

Liu SK, Chen G, Yan B, Huang J, Xu H.

Curr Med Sci. 2019 Apr;39(2):325-329. doi: 10.1007/s11596-019-2038-y. Epub 2019 Apr 23.

PMID:
31016529
9.

RSPO3 is a prognostic biomarker and mediator of invasiveness in prostate cancer.

Mesci A, Lucien F, Huang X, Wang EH, Shin D, Meringer M, Hoey C, Ray J, Boutros PC, Leong HS, Liu SK.

J Transl Med. 2019 Apr 15;17(1):125. doi: 10.1186/s12967-019-1878-3.

10.

Attention Deficits in a Comorbidity-Free Sample of Euthymic Pediatric Bipolar Disorder.

Banerjee N, Liu SK, Sinha VK, Jayaswal M, Desarkar P.

Front Psychiatry. 2019 Mar 21;10:148. doi: 10.3389/fpsyt.2019.00148. eCollection 2019.

11.

Circulating blood miRNAs for prostate cancer risk stratification: miRroring the underlying tumor biology with liquid biopsies.

Hoey C, Liu SK.

Res Rep Urol. 2019 Feb 27;11:29-42. doi: 10.2147/RRU.S165625. eCollection 2019. Review.

12.

SP1-induced up-regulation of lncRNA LUCAT1 promotes proliferation, migration and invasion of cervical cancer by sponging miR-181a.

Zhang L, Liu SK, Song L, Yao HR.

Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):556-564. doi: 10.1080/21691401.2019.1575840.

PMID:
30831032
13.

Combining urinary DNA methylation and cell-free microRNA biomarkers for improved monitoring of prostate cancer patients on active surveillance.

Zhao F, Vesprini D, Liu RSC, Olkhov-Mitsel E, Klotz LH, Loblaw A, Liu SK, Bapat B.

Urol Oncol. 2019 May;37(5):297.e9-297.e17. doi: 10.1016/j.urolonc.2019.01.031. Epub 2019 Feb 16.

PMID:
30777394
14.

Nonlinear frequency conversion and manipulation of vector beams in a Sagnac loop.

Yang C, Zhou ZY, Li Y, Li YH, Liu SL, Liu SK, Xu ZH, Guo GC, Shi BS.

Opt Lett. 2019 Jan 15;44(2):219-222. doi: 10.1364/OL.44.000219.

PMID:
30644865
15.

Molecular landmarks of tumor hypoxia across cancer types.

Bhandari V, Hoey C, Liu LY, Lalonde E, Ray J, Livingstone J, Lesurf R, Shiah YJ, Vujcic T, Huang X, Espiritu SMG, Heisler LE, Yousif F, Huang V, Yamaguchi TN, Yao CQ, Sabelnykova VY, Fraser M, Chua MLK, van der Kwast T, Liu SK, Boutros PC, Bristow RG.

Nat Genet. 2019 Feb;51(2):308-318. doi: 10.1038/s41588-018-0318-2. Epub 2019 Jan 14.

PMID:
30643250
16.

Spurious elevation of Prostate-specific antigen associated with shingles in a prostate cancer patient undergoing active surveillance.

Mesci A, Liu SK, Loblaw DA.

Clin Case Rep. 2018 Oct 22;6(12):2338-2340. doi: 10.1002/ccr3.1838. eCollection 2018 Dec.

17.

Novel liquid fermentation medium of Cordyceps militaris and optimization of hydrothermal reflux extraction of cordycepin.

Luo QY, Cao HF, Liu SK, Wu M, Li SS, Zhang ZQ, Chen AJ, Shen GH, Wu HJ, Li ML, Liu XY, Jiang Y, Bi JF, He ZY.

J Asian Nat Prod Res. 2018 Dec 3:1-12. doi: 10.1080/10286020.2018.1539080. [Epub ahead of print]

PMID:
30507305
18.

Quantum frequency conversion for multiplexed entangled states generated from micro-ring silicon chip.

Li YH, Fang WT, Zhou ZY, Liu SL, Liu SK, Xu ZH, Yang C, Li Y, Xu LX, Guo GC, Shi BS.

Opt Express. 2018 Oct 29;26(22):28429-28440. doi: 10.1364/OE.26.028429.

PMID:
30470014
19.

Direct Quantitative Analysis of Multiple microRNAs (DQAMmiR) with Peptide Nucleic Acid Hybridization Probes.

Hu L, Anand M, Krylova SM, Yang BB, Liu SK, Yousef GM, Krylov SN.

Anal Chem. 2018 Dec 18;90(24):14610-14615. doi: 10.1021/acs.analchem.8b04793. Epub 2018 Dec 4.

PMID:
30451492
20.

Immune infiltrates and PD-L1 expression in treatment-naïve acinar prostatic adenocarcinoma: an exploratory analysis.

Hahn E, Liu SK, Vesprini D, Xu B, Downes MR.

J Clin Pathol. 2018 Nov;71(11):1023-1027. doi: 10.1136/jclinpath-2018-205404. Epub 2018 Sep 26.

PMID:
30257853
21.

Association between obesity and patient-centered measures using the medical expenditure panel survey.

Batsis JA, Lohman MC, Fortuna KL, Liu SK, Bartels SJ.

Obes Res Clin Pract. 2018 Sep - Oct;12(5):485-489. doi: 10.1016/j.orcp.2018.07.009. Epub 2018 Aug 24.

22.

Reproducibility of PD-L1 immunohistochemistry interpretation across various types of genitourinary and head/neck carcinomas, antibody clones, and tissue types.

Wang C, Hahn E, Slodkowska E, Eskander A, Enepekides D, Higgins K, Vesprini D, Liu SK, Downes MR, Xu B.

Hum Pathol. 2018 Dec;82:131-139. doi: 10.1016/j.humpath.2018.07.024. Epub 2018 Aug 1.

PMID:
30075156
23.

Revealing the Behavior of Photons in a Birefringent Interferometer.

Zhou ZY, Liu SK, Liu SL, Li YH, Li Y, Yang C, Xu ZH, Guo GC, Shi BS.

Phys Rev Lett. 2018 Jun 29;120(26):263601. doi: 10.1103/PhysRevLett.120.263601.

PMID:
30004733
24.

Differentiation of Normal and Radioresistant Prostate Cancer Xenografts Using Magnetization Transfer-Prepared MRI.

Lam WW, Oakden W, Murray L, Klein J, Iorio C, Screaton RA, Koletar MM, Chu W, Liu SK, Stanisz GJ.

Sci Rep. 2018 Jul 11;8(1):10447. doi: 10.1038/s41598-018-28731-0.

25.

Limits on Light Weakly Interacting Massive Particles from the First 102.8 kg×day Data of the CDEX-10 Experiment.

Jiang H, Jia LP, Yue Q, Kang KJ, Cheng JP, Li YJ, Wong HT, Agartioglu M, An HP, Chang JP, Chen JH, Chen YH, Deng Z, Du Q, Gong H, He L, Hu JW, Hu QD, Huang HX, Li HB, Li H, Li JM, Li J, Li X, Li XQ, Li YL, Liao B, Lin FK, Lin ST, Liu SK, Liu YD, Liu YY, Liu ZZ, Ma H, Ma JL, Pan H, Ren J, Ruan XC, Sevda B, Sharma V, Shen MB, Singh L, Singh MK, Sun TX, Tang CJ, Tang WY, Tian Y, Wang GF, Wang JM, Wang L, Wang Q, Wang Y, Wu SY, Wu YC, Xing HY, Xu Y, Xue T, Yang LT, Yang SW, Yi N, Yu CX, Yu HJ, Yue JF, Zeng XH, Zeng M, Zeng Z, Zhang FS, Zhang YH, Zhao MG, Zhou JF, Zhou ZY, Zhu JJ, Zhu ZH; CDEX Collaboration.

Phys Rev Lett. 2018 Jun 15;120(24):241301. doi: 10.1103/PhysRevLett.120.241301.

PMID:
29956956
26.

Basal-subtype bladder tumours show a 'hot' immunophenotype.

Hodgson A, Liu SK, Vesprini D, Xu B, Downes MR.

Histopathology. 2018 Nov;73(5):748-757. doi: 10.1111/his.13696. Epub 2018 Aug 14.

PMID:
29947424
27.

miRNA-106a and prostate cancer radioresistance: a novel role for LITAF in ATM regulation.

Hoey C, Ray J, Jeon J, Huang X, Taeb S, Ylanko J, Andrews DW, Boutros PC, Liu SK.

Mol Oncol. 2018 Aug;12(8):1324-1341. doi: 10.1002/1878-0261.12328. Epub 2018 Jun 14.

28.

PD-L1 Immunohistochemistry Assay Concordance in Urothelial Carcinoma of the Bladder and Hypopharyngeal Squamous Cell Carcinoma.

Hodgson A, Slodkowska E, Jungbluth A, Liu SK, Vesprini D, Enepekides D, Higgins K, Katabi N, Xu B, Downes MR.

Am J Surg Pathol. 2018 Aug;42(8):1059-1066. doi: 10.1097/PAS.0000000000001084.

29.

Repaglinide-irbesartan drug interaction: effects of SLCO1B1 polymorphism on repaglinide pharmacokinetics and pharmacodynamics in Chinese population.

Pei Q, Liu JY, Yin JY, Yang GP, Liu SK, Zheng Y, Xie P, Guo CX, Luo M, Zhou HH, Li X, Liu ZQ.

Eur J Clin Pharmacol. 2018 Aug;74(8):1021-1028. doi: 10.1007/s00228-018-2477-6. Epub 2018 May 11.

PMID:
29748863
30.

Male Oncology Research and Education program for men at high risk for prostate cancer.

Lorentz J, Liu SK, Vesprini D.

Curr Oncol. 2018 Apr;25(2):170-175. doi: 10.3747/co.25.3818. Epub 2018 Apr 30.

31.

The effect of systematic lower-limb rehabilitation training in elderly patients undergoing lumbar fusion surgery: a retrospective study.

Liu SK, Song YL, Ding WY, Yang DL, Ma L, Yang SD.

Oncotarget. 2017 Nov 28;8(68):112720-112726. doi: 10.18632/oncotarget.22746. eCollection 2017 Dec 22.

32.

Collagen and Calcium Binding EGF Domains 1 (CCBE1) in cancer - a new role past lymphatics?

Mesci A, Liu SK.

Oncoscience. 2017 Nov 9;4(11-12):168-169. doi: 10.18632/oncoscience.376. eCollection 2017 Nov. No abstract available.

33.

Positive Expression of SMYD2 is Associated with Poor Prognosis in Patients with Primary Hepatocellular Carcinoma.

Zuo SR, Zuo XC, He Y, Fang WJ, Wang CJ, Zou H, Chen P, Huang LF, Huang LH, Xiang H, Liu SK.

J Cancer. 2018 Jan 1;9(2):321-330. doi: 10.7150/jca.22218. eCollection 2018.

34.

Assessment of Serum microRNA Biomarkers to Predict Reclassification of Prostate Cancer in Patients on Active Surveillance.

Liu RSC, Olkhov-Mitsel E, Jeyapala R, Zhao F, Commisso K, Klotz L, Loblaw A, Liu SK, Vesprini D, Fleshner NE, Bapat B.

J Urol. 2018 Jun;199(6):1475-1481. doi: 10.1016/j.juro.2017.12.006. Epub 2017 Dec 12.

PMID:
29246734
35.

Seizure Risk Associated With Antidepressant Treatment Among Patients With Depressive Disorders: A Population-Based Case-Crossover Study.

Wu CS, Liu HY, Tsai HJ, Liu SK.

J Clin Psychiatry. 2017 Nov/Dec;78(9):e1226-e1232. doi: 10.4088/JCP.16m11377.

PMID:
29068610
36.

Coherent frequency bridge between visible and telecommunications band for vortex light.

Liu SL, Liu SK, Li YH, Shi S, Zhou ZY, Shi BS.

Opt Express. 2017 Oct 2;25(20):24290-24298. doi: 10.1364/OE.25.024290.

PMID:
29041374
37.

Impacts of Electroconvulsive Therapy on 1-Year Outcomes in Patients With Schizophrenia: A Controlled, Population-Based Mirror-Image Study.

Lin HT, Liu SK, Hsieh MH, Chien YL, Chen IM, Liao SC, Tsai HJ, Wu CS.

Schizophr Bull. 2018 Jun 6;44(4):798-806. doi: 10.1093/schbul/sbx136.

38.

Computed tomography interobserver agreement in the assessment of aneurysmal subarachnoid hemorrhage and predictors for clinical outcome.

Woo PYM, Tse TPK, Chan RSK, Leung LNY, Liu SKK, Leung AYT, Wong HT, Chan KY.

J Neurointerv Surg. 2017 Nov;9(11):1118-1124. doi: 10.1136/neurintsurg-2016-012576. Epub 2016 Nov 10.

PMID:
29030464
39.

[UPLC-MS/MS determination of tanshinone ⅡA, salvianolic acid B and ginsenoside Rg₁ in Fufang Danshen preparation in rat plasma and brain tissues].

Zhang J, Liu SL, Wang H, Yang GP, Li JP, Liu SK, Tang Z, Pei Q, Huang PH.

Zhongguo Zhong Yao Za Zhi. 2017 Feb;42(3):580-586. doi: 10.19540/j.cnki.cjcmm.2017.0014. Chinese.

PMID:
28952268
40.

MicroRNA-195 Activates Hepatic Stellate Cells In Vitro by Targeting Smad7.

Song LY, Ma YT, Wu CF, Wang CJ, Fang WJ, Liu SK.

Biomed Res Int. 2017;2017:1945631. doi: 10.1155/2017/1945631. Epub 2017 Aug 27.

41.

Carbodicarbenes: Unexpected π-Accepting Ability during Reactivity with Small Molecules.

Chen WC, Shih WC, Jurca T, Zhao L, Andrada DM, Peng CJ, Chang CC, Liu SK, Wang YP, Wen YS, Yap GPA, Hsu CP, Frenking G, Ong TG.

J Am Chem Soc. 2017 Sep 13;139(36):12830-12836. doi: 10.1021/jacs.7b08031. Epub 2017 Aug 30.

PMID:
28813602
42.

Resveratrol alleviates diabetic cardiomyopathy in rats by improving mitochondrial function through PGC-1α deacetylation.

Fang WJ, Wang CJ, He Y, Zhou YL, Peng XD, Liu SK.

Acta Pharmacol Sin. 2018 Jan;39(1):59-73. doi: 10.1038/aps.2017.50. Epub 2017 Aug 3.

43.

Association of Hospital Admission Risk Profile Score with Mortality in Hospitalized Older Adults.

Liu SK, Ward M, Montgomery J, Mecchella JN, Masutani R, Bartels SJ, Batsis JA.

Innov Aging. 2017 Aug 2;1(1):igx007. doi: 10.1093/geroni/igx007. eCollection 2017 Mar 1.

44.

Early biomarker for radiation-induced wounds: day one post-irradiation assessment using hemoglobin concentration measured from diffuse optical reflectance spectroscopy.

Chin LCL, Cook EK, Yohan D, Kim A, Niu C, Wilson BC, Liu SK.

Biomed Opt Express. 2017 Feb 21;8(3):1682-1688. doi: 10.1364/BOE.8.001682. eCollection 2017 Mar 1.

45.

Early surgery for Hong Kong Chinese elderly patients with hip fracture reduces short-term and long-term mortality.

Liu SK, Ho AW, Wong SH.

Hong Kong Med J. 2017 Aug;23(4):374-80. doi: 10.12809/hkmj165005. Epub 2017 Jun 28.

46.

Study of inactive layer uniformity and charge collection efficiency of a p-type point-contact germanium detector.

Ma JL, Yue Q, Wang Q, Li J, Wong HT, Lin ST, Liu SK, Wang L, Jiang H, Yang LT, Jia LP, Chen JH, Zhao W.

Appl Radiat Isot. 2017 Sep;127:130-136. doi: 10.1016/j.apradiso.2017.05.023. Epub 2017 May 30.

PMID:
28586704
47.

Long non-coding RNAs: new frontiers for advancing personalized cancer medicine in prostate cancer.

Ghiam AF, Vesprini D, Liu SK.

Transl Androl Urol. 2017 Apr;6(2):326-330. doi: 10.21037/tau.2017.03.06.

48.

Arsenic trioxide and angiotensin II have inhibitory effects on HERG protein expression: Evidence for the role of PML SUMOylation.

Liu Y, Li D, Nie D, Liu SK, Qiu F, Liu MT, Li YY, Wang JX, Liu YX, Dong CJ, Wu D, Tian W, Yang J, Mu W, Li JT, Zhao D, Wang XF, Chu WF, Yang BF.

Oncotarget. 2017 Jul 11;8(28):45447-45458. doi: 10.18632/oncotarget.17563.

49.

Effects of genetic variants in UGT1A1, SLCO1B3, ABCB1, ABCC2, ABCG2, ORM1 on PK/PD of telmisartan in Chinese patients with mild to moderate essential hypertension
.

Pei Q, Yang L, Tan HY, Liu SK, Liu Y, Huang L, Li RH, Wan Q, Huang J, Guo CX, Zuo XC, Li J, Yang GP.

Int J Clin Pharmacol Ther. 2017 Aug;55(8):659-665. doi: 10.5414/CP202744.

PMID:
28518053
50.

Targeting of CCBE1 by miR-330-3p in human breast cancer promotes metastasis.

Mesci A, Huang X, Taeb S, Jahangiri S, Kim Y, Fokas E, Bruce J, Leong HS, Liu SK.

Br J Cancer. 2017 May 9;116(10):1350-1357. doi: 10.1038/bjc.2017.105. Epub 2017 Apr 18.

Supplemental Content

Support Center